It is important to improve the risk stratification of patients with Barrett esophagus's as well as the prognostication in patients with established esophageal adenocarcinoma.
With this thesis we aimed to evaluate if optimal histological evaluation and use of biomarkers can help to achieve these goals.

L.H.J. Looijenga (Leendert) , F.J. van Kemenade (Folkert) , K. Biermann (Katharina)
Erasmus University Rotterdam
hdl.handle.net/1765/115870
Department of Surgery

ten Kate, F. (2019, April 3). Barrett’s Esophagus and Esophageal Adenocarcinoma : Predictive and Prognostic Biomarkers. Retrieved from http://hdl.handle.net/1765/115870